NCT01584674View on ClinicalTrials.gov

A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne

PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Acne Vulgaris
Interventions
DEVICE

KLOX Biophotonic System

KLOX Biophotonic System (KLOX KLGA0105-01 photo-converter gel and KLOX THERA lamp) will be administered twice a week for 6 weeks followed by a 6-week follow up period

Trial Locations (3)

12462

Attikon University General Hospital, Athens

16121

Andreas Sygros Hospital, Athens

56429

Papageorgiou Hospital, Thessaloniki

Sponsors
All Listed Sponsors
lead

KLOX Technologies Inc.

INDUSTRY